Back
Oncternal Therapeutics Stock Predictions
Elon's Secret "A.I. 2.0" Project
Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project
Sell
37
ONCT
Oncternal Therapeutics
Last Price:
8.39
Seasonality Move:
0.33%
7 Day Trial
ALL ACCESS PASS
$
7
I love this overnight trade happening Thursday
Access my free presentation on these overnight trades right hereOncternal Therapeutics Stock Forecast
- Over the next 52 weeks, Oncternal Therapeutics has on average historically risen by 1.7% based on the past 20 years of stock performance.
- Oncternal Therapeutics has risen higher in 8 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Oncternal Therapeutics Stock Undervalued?
The current Oncternal Therapeutics [ONCT] share price is $8.29. The Score for ONCT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal. - ONCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Oncternal Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Oncternal Therapeutics has on average historically risen by 1.7% based on the past 20 years of stock performance.
Oncternal Therapeutics Stock Rating
Sell
37
Oncternal Therapeutics (ONCT)
is a Sell
Is Oncternal Therapeutics overpriced?
- Oncternal Therapeutics has risen higher in 8 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Oncternal Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
oncternal.com
52-Week Data
52-Week High:
13.14
52-Week Low:
5.57
Prediction Charts
Market Cap:
24.54M
Price in USD:
8.29
Volume:
1.44K
Beta:
1.32
Technical Analysis
SMA50:
8.84
SMA100:
8.82
SMA200:
7.78
52-Wk Change:
40.08%
Stock Predictions
-
Is Oncternal Therapeutics stock public?
Yes, Oncternal Therapeutics is a publicly traded company. -
What is the Oncternal Therapeutics stock quote today?
The Oncternal Therapeutics stock price is 8.29 USD today. -
How to buy Oncternal Therapeutics stock online?
You can buy Oncternal Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-9 | 8.86 | 8.62 | 9.00 | 8.18 |
| Apr-10 | 8.70 | 8.70 | 9.25 | 8.64 |
| Apr-11 | 9.00 | 8.94 | 9.28 | 8.75 |
| Apr-12 | 8.98 | 9.40 | 9.48 | 8.88 |
| Apr-15 | 9.35 | 8.82 | 9.36 | 8.69 |
| Apr-16 | 8.72 | 8.69 | 9.29 | 8.69 |
| Apr-17 | 8.80 | 8.95 | 9.14 | 8.62 |
| Apr-18 | 8.88 | 8.60 | 8.88 | 8.13 |
| Apr-19 | 8.60 | 8.86 | 9.02 | 8.60 |
| Apr-22 | 8.94 | 8.51 | 9.08 | 8.45 |
| Apr-23 | 8.53 | 8.77 | 9.00 | 8.53 |
| Apr-24 | 8.78 | 8.55 | 8.80 | 8.52 |
| Apr-25 | 8.83 | 8.25 | 8.99 | 8.20 |
| Apr-26 | 8.00 | 8.29 | 8.29 | 8.00 |
Oncternal Therapeutics Earnings
Oncternal Therapeutics Earnings Report: Per Share Oncternal Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Oncternal Therapeutics Forecast Revenue Growth
Oncternal Therapeutics Stock Analysis: Historical quarterly revenues per share for Oncternal Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.73 per share, and a decrease next year of $0.56 per share.
* Oncternal Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.